Bally's is an unusual case: rather than a cluster of bullish targets above the stock, the most recent analyst price targets sit below the market price. After the company's second-quarter report in August 2026, Macquarie cut its target to $11 (Neutral), Truist Financial lowered its target to $10 (Hold), and Barclays reduced its target to $7 (Underweight). Stifel maintained $13 (Hold). Taken together, the latest individual targets span roughly $7 to $13, with a mean near $10 to $11 — below the recent price of about $12.
Because no current, credible analyst target is meaningfully above the price, using a conventional average analyst price target would produce a figure below where the stock already trades, which is not a useful reference point. The $15 level used here therefore reflects public discussion rather than an analyst consensus: it is the round-number recovery milestone that would return the stock toward the higher end of the objectives analysts cited earlier in 2026, before the going-concern disclosure. It should not be read as a published or consensus forecast.
Bally's Corporation (BALY) is a global casino, hospitality, and interactive gaming company with roughly 20 casinos across 11 U.S. states and one in the U.K., plus sports betting, iCasino, and a majority stake in lottery operator Intralot. With the stock near $12 and a market capitalization around $600 million, reaching $15 would represent about a 25% gain — a substantial move that would still leave the shares well below their 52-week high of roughly $19.60 to $20.74.
The path to $15 would likely require resolving the concerns that have driven the stock down. The company reported strong top-line momentum — preliminary third-quarter 2026 revenue of $807.6 million, up 21.7% year over year — but profitability remains negative, and the August quarter included a "going concern" disclosure (a warning that there is doubt about the company's ability to continue operating) that triggered a sharp sell-off of more than 25% in a single session. Regaining investor confidence in liquidity and debt reduction is central to any recovery in the share price.
Bally's most compelling support is its revenue growth and development pipeline. Quarterly revenue has been rising in the 20% to 28% range year over year, helped by organic gains and the completed acquisition of Queen Casino & Entertainment. The company has secured substantial financing tied to growth projects, including a commitment from Gaming and Leisure Properties covering much of the cost of the Chicago casino and a term loan package for the Bronx development. Sale-leaseback transactions on properties in Kansas City, Shreveport, and Twin River Lincoln have also raised cash to fund these projects.
If management can demonstrate progress toward positive adjusted cash flow, reduced leverage, and on-schedule project openings, the narrative could shift from distress to a turnaround, supporting a re-rating of the shares toward levels analysts cited earlier in the year.
The obstacles are substantial. Lease-adjusted leverage has been cited near 6.5 times EBITDA (earnings before interest, taxes, depreciation, and amortization), among the highest in gaming coverage, and the company carries a sub-investment-grade credit profile. The going-concern warning, a CFO resignation, delayed 10-Q filings, and shareholder investigations into potential securities claims all weigh on sentiment. Net losses, negative operating cash flow, and large development commitments leave limited room for error. If liquidity concerns resurface or project timelines slip, the stock could remain under pressure rather than recover.
From a technical standpoint, the shares have been volatile, trading between a 52-week low near $8.44 and a high near $19.60 to $20.74. The stock sits below its 50-day moving average of roughly $12.47 and its 200-day moving average near $12.77 — levels that have acted as resistance during recent rallies. A durable push toward $15 would likely need to clear the $13 area first, a prior analyst-target zone and round-number resistance level. On the downside, the $8.44 low is the key support level to watch.
Analyst price targets typically reflect a roughly 12-month research horizon, though Bally's coverage has been revised repeatedly, so individual timeframes differ. Investors should watch the next earnings report and any guidance on liquidity, the resolution of delayed filings, refinancing or deleveraging activity, construction milestones in Chicago and the Bronx, and any updates on the shareholder investigations. Analyst revisions have been frequent and materially negative, so further target changes are a key signal for the market outlook.
For traders tracking names like Bally's, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to fundamental research. The system uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover opportunities, monitor existing positions, and spot shifting trends more efficiently. Exploring these signals alongside your own analysis can help you stay ahead of rapid changes in volatile names like BALY.
Can Bally's Corporation reach $15? The question hinges on a turnaround that has not yet been demonstrated. The $15 level is a recovery milestone drawn from public discussion and earlier, higher analyst objectives — not a current consensus, since the latest targets of $7 to $13 sit at or below the price. Reaching $15 would require about a 25% gain, driven by sustained revenue growth, progress on deleveraging, and restored confidence in the company's financial footing. The principal obstacles — the going-concern disclosure, heavy leverage, leadership turnover, delayed filings, and ongoing investigations — are significant. Investors should monitor liquidity, earnings, project execution, and analyst revisions rather than treat $15 as a guaranteed outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that BALY and INSE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BALY and INSE's prices will move in lockstep.
| Ticker / NAME | Correlation To BALY | 1D Price Change % | ||
|---|---|---|---|---|
| BALY | 100% | +0.25% | ||
| INSE - BALY | 32% Poorly correlated | +16.98% | ||
| HGV - BALY | 27% Poorly correlated | +2.11% | ||
| PENN - BALY | 27% Poorly correlated | -0.49% | ||
| MGM - BALY | 24% Poorly correlated | +0.46% | ||
| CZR - BALY | 24% Poorly correlated | +0.07% | ||
More | ||||
| Ticker / NAME | Correlation To BALY | 1D Price Change % |
|---|---|---|
| BALY | 100% | +0.25% |
| Hotels/Resorts/Cruiselines industry (17 stocks) | 29% Poorly correlated | -1.23% |